SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.52 HKD | +0.15% |
|
+3.84% | -20.47% |
| 05-15 | Fosun Pharma Unit Fosun Health to Receive Capital Injection from Foshan Chanxi City Investment | MT |
| 05-15 | China Approves Clinical Trials For Breast Cancer Drugs | MT |
Evolution of the average Target Price on Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
4a05c2079.yA9tP4CeNM-0hdI9KIPP38VmCqBUMXmcXOVvQn-lFQ4.qX1eUdX7BabG85tYZe67ifETTJc5ax7FP6QHCTP2dmq5bVRrsst4jJn3kw~b53786b84c3eb94b2e414012a5140e6e
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
23.78
CNY
Average target price
28.61
CNY
Spread / Average Target
+20.30%
High Price Target
35
CNY
Spread / Highest target
+47.18%
Low Price Target
24.5
CNY
Spread / Lowest Target
+3.03%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- 600196 Stock
- 2196 Stock
- Consensus Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
